<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=windows-1251">
<title>Нежелательные лекарственные реакции и взаимодействия при антибиотикотерапии инфекций мочевыводящих путей</title>
<meta name="Description" content="Нежелательные лекарственные реакции и взаимодействия при антибиотикотерапии инфекций мочевыводящих путей. Методическиое пособие.">
<meta name="keywords" content="">
<script language="JavaScript1.2">
<!--
function btn(ind,picture) {document.images[ind].src=picture;}
-->
</script>

<script language="JavaScript">
<!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/rus/include/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../../include/ie.css"></noscript>

<style type="text/css">
P {margin-top: 10px; margin-left: 2px; margin-left: 2px; text-align: justify; }
LI {margin-left: 5px; margin-top: 6px;}
UL {margin-top: 6px; margin-left: 13px; margin-bottom: 5px;}
OL {margin-top: 6px; margin-left: 25px;}
H4 {margin-left: 2px; margin-bottom: 7px;}
TD.sm {font-size: 8pt; color: #581818; vertical-align: top; line-height: 125%; }
</style>
</head>

<body class="main">
<center>

<table width="750" cellpadding="0" border="0" cellspacing="0">
  <tr><td>
<!--navigation-->
<map name="TopBtn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Предыдущая страница" title="Предыдущая страница">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Следующая страница" title="Следующая страница">
<area shape="circle" coords="77,15,15" href="../../../../index.htm" alt="Главная страница сайта" title="Главная страница сайта">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="Написать письмо" title="Написать письмо">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../images/buttons/topline.gif);" width="98%" height="32"><img src="../../../images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Навигация" usemap="#TopBtn"></font></td>
</tr>
</table>
<!--/navigation-->
<p class="c"><b>Смоленская государственная медицинская академия</b></p>
<br>
<h3>НЕЖЕЛАТЕЛЬНЫЕ ЛЕКАРСТВЕННЫЕ РЕАКЦИИ И ВЗАИМОДЕЙСТВИЯ <br>ПРИ АНТИБИОТИКОТЕРАПИИ ИНФЕКЦИЙ МОЧЕВЫВОДЯЩИХ ПУТЕЙ</h3>

<p class="c"><b>методическое пособие</b></p>

<hr size="1" color="Navy" noshade="">
<table border="0" cellpadding="5" cellspacing="0" align="center">
<tr>
  <td class="sm" valign="top"><a href="index.shtml">Содержание</a></td>
  <td class="sm" colspan="3">НР и лекарственные взаимодействия антибиотиков, наиболее часто применяемых для лечения ИМП</td>
</tr>

<tr>
  <td class="sm" valign="top" width="15%"><a href="01.shtml#g1">Резюме</a><br><br>
<a href="01.shtml#g2">Сокращения</a><br><br>
<a href="04.shtml#g11">Литература</a></td>
  <td class="sm" valign="top" width="28%">
<a href="01.shtml#g3"><font face="Symbol">b</font>-лактамы:</a>
<ul style="margin-top: 0px; margin-bottom: 0px">
<a href="01.shtml#g3_1">Аминопенициллины</a><br>
<a href="01.shtml#g3_2">Ингибитор-защищенные <br>аминопенициллины<br>Амоксициллин/клавуланат</a><br><a href="01.shtml#g3_3">Цефалоспорины</a><br></ul></td>

	<td class="sm" valign="top" width="30%">
<a href="02.shtml#g4">Аминогликозиды</a><br>
<a href="02.shtml#g5">Ко-тримоксазол</a><br>
<a href="02.shtml#g6">Нефторированные хинолоны:
<ul style="margin-top: 0px; margin-bottom: 0px">налидиксовая, оксолиниевая, пипемидовая кислота</ul></a>
<a href="03.shtml#g7">Фторхинолоны</a></td>
  <td class="sm" valign="top" width="27%">  
<a href="03.shtml#g8">Нитрофураны:</a><br>
<ul style="margin-top: 0px; margin-bottom: 0px"><a href="03.shtml#g8_1">Нитрофурантоин</a><br>
<a href="03.shtml#g8_2">Фуразидин</a><br></ul>
<a href="03.shtml#g9">Фосфомицина трометамол</a><br>
<a href="03.shtml#g10">Хинолины</a><br></td>
</tr>
</table>
<hr size="1" color="Navy" noshade="">


<a name="g11"></a><br>
<h3>Литература</h3>

<ol>
<li value="1"><a name="l1"></a>White T.J. Counting the Cost of Drug-Related Adverse Events. Pharmacoeconomics 1999; 15: 445-458.</li>
<li value="2"><a name="l2"></a>Lazarou J., Pomeranz B., Corey P. Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA 1998; 279: 1200-1205.</li>
<li value="3"><a name="l3"></a>Garcia Rodriguez L.A., Stricker B.H., Zimmerman H.J. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327-1332.</li>
<li value="4"><a name="l4"></a>Limauro D.L., Chan-Tompkins N.H., Carter R.W. e.a. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome. Ann Pharmacother 1999; 33: 560-564.</li>
<li value="5"><a name="l5"></a>Neu H.C., Wilson A.P.R., Gruneberg R.N. Amoxycillin/Clavulanic Acid: a Review of its Efficacy in over 38,500 Patients from 1979 to 1992. J Chemother 1993; 5: 67-93.</li>
<li value="6"><a name="l6"></a>Thompson J.W., Jacobs R.F. Adverse effects of newer cephalosporins. An update. Drug Saf 1993; 9: 132-142.</li>
<li value="7"><a name="l7"></a>Norrby S.R. Side Effects of Cephalosporins. Drugs 1995; 34 (Suppl. 2): 105-120.</li>
<li value="8"><a name="l8"></a>Karchmer A.W. In: Principles and Practice of Infectious Diseases / Ed. by G. L. Mandel, J.E. Bennett, R. Dolin.- 5th ed.- Philadelphia, 2000.- P. 275-291.</li>
<li value="9"><a name="l9"></a>Hoitsma A.J., Wetzels J.F., Koene R.A. Drug-induced nephrotoxicity. Aetiology, clinical features and management. Drug Saf 1991; 6: 131-147.</li>
<li value="10"><a name="l10"></a>McCarty J.M., Richard G., Huck W. e.a. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999; 106: 292-299.</li>
<li value="11"><a name="l11"></a>Naldi L., Conforti A., Venegoni M. et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846.</li>
<li value="12"><a name="l12"></a>Mockenhaupt M., Schopf E. / Progress in Allergy and Clinical Immunology, vol. 4, Cancun (Mexico): proceedings of the XVIth International Congress of Allergology and Clinical Immunology, Cancun, Mexico, 1997.- P. 352-360.</li>
<li value="13"><a name="l13"></a>Mahboob A., Haroon T.S. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.</li>
<li value="14"><a name="l14"></a>van der Klauw M.M., Wilson J.H., Stricker B.H. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clin Exp Allergy 1996; 26: 1355-1363.</li>
<li value="15"><a name="l15"></a>Pedersen-Bjergaard U., Andersen M., Hansen P.B. . Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968-91. J Intern Med 1996; 239: 509-515.</li>
<li value="16"><a name="l16"></a>Miyagawa S., Yamashina Y., Hirota S., Shirai T. . Fixed drug eruption due to pipemidic acid. J Dermatol 1991; 18: 59-60.</li>
<li value="17"><a name="l17"></a>Ball P., Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf 1995; 13: 343-358. </li>
<li value="18"><a name="l18"></a>Harrell R.M. Fluoroquinolone-Induced Tendinopathy: What Do We Know? South Med J 1999; 92: 622-625.</li>
<li value="19"><a name="l19"></a>Lipsky B.A., Baker C.A. Fluoroquinolone Toxicity Profiles: A Review Focusing on Newer Agents. Clin Infect Dis 1999; 28: 352-364.</li>
<li value="20"><a name="l20"></a>Henry D.C., Nenad R.C., Iravani A. et al. . Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin Ther 1999; 21: 966-981.</li>
<li value="21"><a name="l21"></a>Scrip.- 1996.- N. 2153.- P.16.</li>
<li value="22"><a name="l22"></a>Kashida Y., Kato M. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob Agents Chemother 1997; 41: 2389-2393.</li>
<li value="23"><a name="l23"></a>Bottiger L.E., Westerholm B. Adverse drug reactions during treatment of urinary tract infections. Eur J Clin Pharmacol 1977; 11: 439-442.</li>
<li value="24"><a name="l24"></a>Hallas J., Gram L.F., Grodum E., Damsbo N., Brosen K., Haghfelt T. et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61-68. </li>
<li value="25"><a name="l25"></a>Jick S.S., Jick H., Walker A.M., Hunter J.R. Hospitalizations for pulmonary reactions following nitrofurantoin use. Chest 1989; 96: 512-515.</li>
<li value="26"><a name="l26"></a>Hooper D.C. In G.L. Mandell, J.E. Bennett, and R. Dolin (eds.) / Principles and Practice of Infectious Diseases (4th ed.). New York: Churchill Livingstone, 1995. P. 376-381.</li>
<li value="27"><a name="l27"></a>Gait J.E. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990; 24: 1210-1213.</li>
<li value="28"><a name="l28"></a>Uhari M., Nuutinen M., Turtinen J. Turtinen  Adverse reactions in children during long-term antimicrobial therapy. Pediatr Infect Dis J 1996; 15: 404-408.</li>
<li value="29"><a name="l29"></a>Zielonka T.M., Demkow U., Kus J. Pulmonary reaction after furazidin (Furagin). Case report. Pol Arch Med Wewn 1997; 97: 465-472. </li>
<li value="30"><a name="l30"></a>Crocchiolo P. Single-Dose Fosfomycin Trometamol versus Multiple-Dose Cotrimaxazole in the Treatment of Lower Urinary Tract Infections in General Practice. Chemotherapy 1990; 36: 37-40.</li>
<li value="31"><a name="l31"></a>Patel S.S., Balfour J.A., Bryson H.M. Fosfomycin Tromethamine. Drugs 1997; 53: 637-656.
<li value="32"><a name="l32"></a>Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs // Pediatrics.- 1974.- Vol. 54.- P. 378-379.</li>
<li value="33"><a name="l33"></a>Hutzler D., Pevny I. Allergies to 8-hydroxyquinoline derivatives. Derm Beruf Umwelt 1988; 36: 86-90.</li>
<li value="34"><a name="l34"></a>Rose F.C., Gawel M. Clioquinol neurotoxicity: An overview. Acta Neurol Scand 1978; 70 (suppl 100): 137-145.</li>
</ol>

<br>
<!--footer-->
<table border="0" cellpadding="0" cellspacing="1" width="100%"><tr>
<td align="left" style="vertical-align:bottom;"><font class="t8">&copy; 2000-2009 <a target="_blank" href="../../../../copyright.php.html">НИИАХ СГМА</a></font></td>

<td colspan="2" align="right"><font size="1">
<!--Rambler 1x1--><a href="http://top100.rambler.ru/top100/"><img src="../../../../top100.cnt.gif?335834" alt="Rambler's Top100" width="1" height="1" border="0"></a><!--/Rambler 1x1-->

<!--LiveInternet 1x1--><script language="JavaScript"><!--
document.write('<img src="http://counter.yadro.ru/hit?r'+
escape(document.referrer)+((typeof(screen)=='undefined')?'':
';s'+screen.width+'*'+screen.height+'*'+(screen.colorDepth?
screen.colorDepth:screen.pixelDepth))+';u'+escape(document.URL)+
';i'+escape('Жж'+document.title.substring(0,80))+';'+Math.random()+
'" width=1 height=1 alt="">')
//--></script><!--/LiveInternet-->

<!--LiveInternet--><a href="../../../../index-17.htm" target="_blank"><img src="../../../../images/banners/rax.gif" border="0" width="31" height="31" title="liveinternet.ru"></a><!--/LiveInternet-->

<!--TopList--><a href="http://top.list.ru/jump?from=96637" target="_blank"><img src="../../../../counter-3.gif?id=96637;t=55" border="0" height="31" width="88" alt="TopList"></a><!--/TopList-->

<!--Rambler--><a href="http://top100.rambler.ru/top100/" target="_blank"><img src="../../../../top100/banner-88x31-rambler-darkblue2.gif" alt="Rambler's Top100" width="88" height="31" border="0"></a><!--/Rambler-->
</font>
</td>

</tr></table>
<!--/footer-->

<hr size="1">
  </td></tr>
</table>
</center>
</body>
</html>
